RIVERVIEW BANCORP, INC.

RVSB

CIK 0001041368 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$16M
↑+5.6% +$841Kvs FY2024 (Q4)
Operating Income
$16M
↑+5.6% +$843Kvs FY2024 (Q4)
Net Income
$1M
↑+11.8% +$145Kvs FY2024 (Q4)
Gross Profit
$16M
↑+5.6% +$841Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
6/100
  • Profitability
    0Insufficient data
  • Liquidity
    0Insufficient data
  • Leverage
    0Insufficient data
  • Efficiency
    0Asset Turnover 0.04x (1.0+ = capital-efficient)
  • Growth
    35Revenue YoY +5.6% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project RVSB's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -25.1%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$3.68
Total enterprise IV
$78M
Diluted shares
0.02B
Terminal PV
$55M (70% of total)
Year-5 FCF
$6M
YearProjected FCFDiscounted PV
+1$6M$5M
+2$6M$5M
+3$6M$5M
+4$6M$4M
+5$6M$4M
Terminal$88M$55M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$791K
investment in PP&E
Dividends paid (TTM)
$2M
cash returned to holders
Stock buybacks (TTM)
$2M
share count reduction
Stock-based comp (TTM)
$542K
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$1.51B
everything owned
Total liabilities
$1.35B
everything owed
Stockholders' equity
$164M
shareholder claim

Recent performance · 63 quarters

Revenue↑+5.6% +$841K
$16M
Net Income↑+11.8% +$145K
$1M
Free Cash Flow↓-112.1% -$2M
$-230K

Drill down